These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17521)

  • 1. Absorption, excretion and disposition of cyclindole in laboratory animals and human volunteers.
    Benziger DP; Balfour K; Clemans S; Edelson J
    Drug Metab Dispos; 1977; 5(3):239-45. PubMed ID: 17521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption and disposition of oxarbazole in man and laboratory animals.
    Benziger D; Dorrbecker S; Goehl T; Edelson J
    Drug Metab Dispos; 1978; 6(1):8-15. PubMed ID: 23278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of a series of tetrahydrocarbazoles.
    Edelson J; Benziger DP
    Drug Metab Rev; 1980; 11(2):263-89. PubMed ID: 7011760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of [14C]iprindole in man, dog, miniature swine, rhesus monkey and rat.
    Sisenwine SF; Tio CO; Ruelius HW
    Xenobiotica; 1979 Apr; 9(4):237-46. PubMed ID: 113942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
    Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
    Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in the metabolism and disposition of spironolactone.
    Karim A; Kook C; Zitzewitz DJ; Zagarella J; Doherty M; Campion J
    Drug Metab Dispos; 1976; 4(6):547-55. PubMed ID: 11976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological disposition and metabolism of timolol in man and laboratory animals.
    Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
    Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences.
    Lan SJ; El-Hawey AM; Dean AV; Schreiber EC
    Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys.
    Whitaker NG; Lindstrom TD
    Drug Metab Dispos; 1987; 15(1):107-13. PubMed ID: 2881745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
    Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW
    Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
    DeLong AF; Smyth RD; Polk A; Nayak RK; Martin G; Douglas GH; Reavey-Cantiwell NH
    Drug Metab Dispos; 1977; 5(2):122-31. PubMed ID: 15804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man.
    Hucker HB; Stauffer SC; Balletto AJ; White SD; Zacchei AG; Arison BH
    Drug Metab Dispos; 1978; 6(6):659-72. PubMed ID: 33029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of p-methoxyamphetamine in dog and monkey. O-demethylation as a major route.
    Hubbard JW; Midha KK; Cooper JK
    Drug Metab Dispos; 1977; 5(4):329-34. PubMed ID: 19212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and excretion of atorvastatin in rats and dogs.
    Black AE; Hayes RN; Roth BD; Woo P; Woolf TF
    Drug Metab Dispos; 1999 Aug; 27(8):916-23. PubMed ID: 10421619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption and disposition of [14C]-molsidomine in laboratory animals.
    Fromson JM; Illing HP; Ings RM; Johnson KI; Johnson P; Ostrowski J; Schraven E; Steward A
    Arzneimittelforschung; 1981; 31(2):337-45. PubMed ID: 6894378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin) in beagle dogs and rhesus monkeys.
    Janssen FW; Kirkman SK; Knowles JA; Ruelius HW
    Drug Metab Dispos; 1978; 6(4):465-75. PubMed ID: 28928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.